Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial. [electronic resource]
Producer: 20120111Description: 1427-39 p. digitalISSN:- 1432-0584
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- therapeutic use
- Female
- Glucocorticoids -- therapeutic use
- Humans
- Immunosuppressive Agents -- therapeutic use
- Male
- Melphalan -- therapeutic use
- Middle Aged
- Models, Statistical
- Multiple Myeloma -- drug therapy
- Prednisone -- therapeutic use
- Prospective Studies
- Quality of Life
- Surveys and Questionnaires
- Thalidomide -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.